Question 1

How much would I have if I DCA'd $100/week into COR for 5 years?

Accepted Answer

Dollar cost averaging $100 per week into COR for 5 years (261 purchases) would have resulted in a total investment of $26,100 and a current value of $41,365, a return of 58%. Using Enhanced DCA, which concentrates buys during dips, the same $100/week base deployed $19,155 and grew to $32,437 — a 69% return.

Question 2

What is the best DCA strategy for COR?

Accepted Answer

Backtesting shows Enhanced DCA — which increases buy amounts during market dips and reduces or skips buys when COR is overextended — outperformed standard weekly DCA by 11% over 5 years. The enhanced strategy achieved a 69% return vs 58% for standard DCA.

Question 3

What would $100/week into COR be worth after 3 years?

Accepted Answer

Investing $100 per week into COR for 3 years (157 purchases, $15,700 total) would have grown to $19,302 — a 23% return. Enhanced DCA over the same period returned 25%.

Question 4

Is DCA into COR worth it?

Accepted Answer

Based on a 5-year backtest, DCA into COR returned 58% with standard weekly purchases. An intelligent DCA strategy that buys more during dips returned 69% over the same period — a 11% gain in return, while deploying a similar or smaller amount of capital.

Question 5

How many shares of COR would I have after DCA for 5 years?

Accepted Answer

Dollar cost averaging $100/week into COR for 5 years would result in approximately 128 shares with a standard DCA approach (avg entry $204). Enhanced DCA targeting dips results in 100 shares at an average entry of $191.

Question 6

How does COR DCA compare to the S&P 500?

Accepted Answer

Enhanced DCA into COR returned 69% over the past 5 years. The S&P 500 (SPY) returned approximately 53% over the same period. COR's performance reflects its volatility as a healthcare asset. Enhanced DCA outperformed standard DCA by 11%, demonstrating the value of intelligent entry timing during market dips.

Question 7

What is the risk of dollar cost averaging into COR?

Accepted Answer

Past backtest performance does not guarantee future results. COR is a healthcare asset whose price can fall as well as rise. While DCA reduces timing risk by spreading purchases over time, losses are still possible if the price declines significantly. Always invest within your risk tolerance and consider your overall portfolio diversification.

Question 8

What is the Cencora dollar cost averaging strategy?

Accepted Answer

Standard DCA invests a fixed amount ($100/week or $433/month) into COR at regular intervals. Enhanced DCA improves on this by using RSI (Relative Strength Index) signals to increase buy amounts during market dips (oversold conditions) and reduce or skip purchases when the stock is overextended. Over the 5-year backtest, this timing approach has delivered 11% higher returns than standard DCA while deploying less total capital into COR.

Period	Standard DCA	Enhanced DCA	Alpha
1-Year	1%	10%	+9%
3-Year	23%	25%	+2%
5-Year	58%	69%	+11%

COR DCA Backtest — Dollar Cost Averaging Results

COR DCA Results: Key Findings

Alpha you missed while unsubscribed

Dollar cost averaging into COR — backtest results

Buying the dips for Cencora